A study in chronic myeloid leukemia showed that the administration of proteasome inhibitor oprozomib could induce cell apoptosis via ASK-JNK-Bim axis (Wang et al., 2021). This evidence concerns the gene BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive.